药理学sci期刊推荐

　药理学sci期刊推荐，sci期刊是有分区划分的，对论文的要求是比较高的，发表sci论文要提前了解清楚要求并选择符合的刊物投稿。艾德思给您准备以下详细内容介绍。

　药理学sci期刊有哪些?sci期刊是有分区划分的，对论文的要求是比较高的，发表sci论文要提前了解清楚要求并选择符合的刊物投稿。需要注意的是并不是所有的期刊都适合发表论文的，接下来，详细的推荐四本sci期刊，仅供参考。

　　1、JOURNAL OF PHARMACY AND PHARMACOLOGY

　　学科领域：

　　大类：医学

　　小类：药学

　　中科院分区：3区

　　期刊简介：JPP keeps pace with new research on how drug action may be optimized by new technologies, and attention is given to understanding and improving drug interactions in the body. At the same time, the journal maintains its established and well-respected core strengths in areas such as pharmaceutics and drug delivery, experimental and clinical pharmacology, biopharmaceutics and drug disposition, and drugs from natural sources. JPP publishes at least one special issue on a topical theme each year.

　　2、TOXICOLOGY

　　学科领域：

　　大类：医学

　　小类：药学

　　中科院分区：3区

　　期刊简介：Toxicology is an international, peer-reviewed journal that publishes only the highest quality original scientific research and critical reviews describing hypothesis-based investigations into mechanisms of toxicity associated with exposures to xenobiotic chemicals, particularly as it relates to human health. In this respect "mechanisms" is defined on both the macro (e.g. physiological, biological, kinetic, species, sex, etc.) and molecular (genomic, transcriptomic, metabolic, etc.) scale. Emphasis is placed on findings that identify novel hazards and that can be extrapolated to exposures and mechanisms that are relevant to estimating human risk. Toxicology also publishes brief communications, personal commentaries and opinion articles, as well as concise expert reviews on contemporary topics. All research and review articles published in Toxicology are subject to rigorous peer review. Authors are asked to contact the Editor-in-Chief prior to submitting review articles or commentaries for consideration for publication in Toxicology.

　　3、CNS DRUGS

　　学科领域：

　　大类：医学

　　小类：药学

　　中科院分区：2区

　　期刊简介：CNS Drugs promotes rational pharmacotherapy within the disciplines of clinical psychiatry and neurology. The Journal includes:

　　- Overviews of contentious or emerging issues.

　　- Comprehensive narrative reviews that provide an authoritative source of information on pharmacological approaches to managing neurological and psychiatric illnesses.

　　- Systematic reviews that collate empirical evidence to answer a specific research question, using explicit, systematic methods as outlined by the PRISMA statement.

　　- Adis Drug Reviews of the properties and place in therapy of both newer and established drugs in neurology and psychiatry.

　　- Original research articles reporting the results of well-designed studies with a strong link to clinical practice, such as clinical pharmacodynamic and pharmacokinetic studies, clinical trials, meta-analyses, outcomes research, and pharmacoeconomic and pharmacoepidemiological studies.

　　4、BIODRUGS

　　学科领域：

　　大类：医学

　　小类：药学

　　中科院分区：2区

　　期刊简介：An essential resource for R&D professionals and clinicians with an interest in biologic therapies.

　　BioDrugs covers the development and therapeutic application of biotechnology-based pharmaceuticals and diagnostic products for the treatment of human disease.

　　BioDrugs offers a range of additional enhanced features designed to increase the visibility, readership and educational value of the journal’s content. Each article is accompanied by a Key Points summary, giving a time-efficient overview of the content to a wide readership. Articles may be accompanied by plain language summaries to assist patients, caregivers and others in understanding important medical advances. The journal also provides the option to include various other types of enhanced features including slide sets, videos and animations. All enhanced features are peer reviewed to the same high standard as the article itself. Peer review is conducted using Editorial Manager®, supported by a database of international experts. This database is shared with other Adis journals.